Used in pharmaceutical research as a chiral building block for developing neuroactive compounds. Shows potential in the synthesis of agents targeting central nervous system disorders due to its structural similarity to known neurotransmitter modulators. Its pyrrolidine and oxadiazole moieties contribute to blood-brain barrier permeability and metabolic stability, making it valuable in drug design for cognitive and psychiatric conditions. Also explored in the development of selective enzyme inhibitors and receptor ligands.